Surveillance Approach for Patients With Precancerous Stomach Conditions to Identify Cancer Risk and Guide Follow-Up
Led by University of Latvia · Updated on 2018-08-21
2000
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Gastric cancer remains a serious health concern with high mortality rates, especially in Latvia where many cases are diagnosed late. This research aims to identify groups of patients with precancerous stomach lesions who have different risks of developing gastric cancer. The goal is to determine the right follow-up intervals and focus endoscopic surveillance on those at high risk, following European guidelines for managing precancerous stomach conditions.
Participants will undergo upper endoscopy with biopsies to identify and classify gastric lesions, including testing for Helicobacter pylori infection. Blood plasma or serum samples will be collected to assess biomarkers and aid in risk group classification. Additional biopsies and fecal samples will be taken to analyze gastric and fecal microbiota. Surveillance will be targeted mainly to high-risk patients, with follow-up gastroscopies scheduled based on initial findings and pathology reports.
During the study, participants will have assessments at baseline and then one and three years later, including endoscopic procedures and sample collections. Researchers will monitor risk stratification and the composition of gastric and fecal microbiomes. The study allows for long-term observation to better understand progression risks, with participation involving regular medical evaluations and laboratory testing over the study period ending in 2027.
CONDITIONS
Brief Title
Surveillance of Patients With Precancerous Lesions of the Stomach
Research Team
I
Ilze Kikuste, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Surveillance
Duration - Up to 3 years depending on histopathological reports
Participants undergo targeted endoscopic surveillance to monitor precancerous conditions and lesions of the stomach, including biopsies and sample collections for risk stratification.
Follow-up gastroscopies and sample collections at baseline, 1 year, and 3 years
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
7
Similar Trials
Evaluation of 18FFAPI-74 PET Imaging Compared to Standard Methods for Detecting Multiple Cancer Types
Safety and Effectiveness of Indocyanine Green Imaging in Advanced Gastric Cancer Surgery Using 3D and Ultra High Resolution Laparoscopy
Phase 12a Study of 64Cu-LNTH-1363S PETCT Imaging in Patients with Sarcoma or Gastrointestinal Tract Cancer
Evaluating Safety, Dosage, and Imaging Correlation with FAP Expression
Study of 18FFAPI PETCT and Laparoscopy to Improve Staging and Treatment Decisions in Advanced Gastric Cancer
Study of 18FFPyQCP PET Imaging for Fibroblast Activation Protein in Selected Cancers
Phase 2 Study of Systemic Chemotherapy, Immune Checkpoint Inhibitors, and HIPEC for Treating Gastric Cancer with Peritoneal Metastasis
Phase III Randomized Trial Comparing Albumin-bound Docetaxel and Taxotere for Advanced or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Phase I Study of Intravenous CEA-Targeted CAR-T Therapy for Advanced CEA Positive Solid Tumors
Mobile Capsule Gastroscopy to Detect Gastric Diseases in Elderly and High-Risk Adults
A Large Prospective Study in Community Health Centers
Phase 2 Study of SAR445877 as Monotherapy for Adults With Advanced Gastric or Gastroesophageal Junction Cancer in China
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).